Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Dose”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00955175
What this trial is testing

Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09

Who this might be right for
Lung Cancer
Cancer Trials Ireland 60
Testing effectiveness (Phase 2)Study completedNCT00126165
What this trial is testing

Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alberta Health services 72
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Early research (Phase 1)UnknownNCT00960167
What this trial is testing

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT03294889
What this trial is testing

ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Geneva 45
Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Early research (Phase 1)Study completedNCT01215500
What this trial is testing

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

Who this might be right for
TumorCancerMelanoma+2 more
University of Chicago 63
Not applicableStudy completedNCT07489729
What this trial is testing

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Who this might be right for
Hypofractionated DoseProstate Cancer Patients
Tanta University 60
Testing effectiveness (Phase 2)Study completedNCT00907569
What this trial is testing

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmSmall Cell Carcinoma
AHS Cancer Control Alberta 2
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT00129025
What this trial is testing

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alberta Health services 35
Not applicableLooking for participantsNCT07021846
What this trial is testing

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

Who this might be right for
Breast Cancer
Fondazione Policlinico Universitario Campus Bio-Medico 132
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Not applicableLooking for participantsNCT05665920
What this trial is testing

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Who this might be right for
Malignant Breast Neoplasm
Instituto Brasileiro de Controle do Cancer 36
Testing effectiveness (Phase 2)Looking for participantsNCT05963490
What this trial is testing

Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer

Who this might be right for
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University 108
Testing effectiveness (Phase 2)UnknownNCT00938418
What this trial is testing

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage III Non-Small Cell Lung Cancer
National University Hospital, Singapore 43
Testing effectiveness (Phase 2)UnknownNCT05588206
What this trial is testing

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 21
Testing effectiveness (Phase 2)Looking for participantsNCT06386315
What this trial is testing

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Who this might be right for
Indolent B-Cell Non-Hodgkin LymphomaRecurrent Indolent B-Cell Non-Hodgkin LymphomaRefractory Indolent B-Cell Non-Hodgkin Lymphoma+2 more
Mayo Clinic 112
Testing effectiveness (Phase 2)Study completedNCT00714753
What this trial is testing

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 5
Load More Results